Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
about
Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognitionCrystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groovePhotocrosslinkable pMHC monomers stain T cells specifically and cause ligand-bound TCRs to be 'preferentially' transported to the cSMAC.Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity.New synthetic non-peptide ligands for classical major histocompatibility complex class I molecules.VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.Nonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoter.Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.Mucosally delivered peptides prime strong immunity in HLA-A2.1 transgenic rabbits.Cognate peptides induce self-destruction of CD8+ cytolytic T lymphocytesPeptide-MHC heterodimers show that thymic positive selection requires a more restricted set of self-peptides than negative selection.Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.A short polypeptide from the herpes simplex virus type 2 ICP10 gene can induce antigen aggregation and autophagosomal degradation for enhanced immune presentation.High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model.Endogenous matrix metalloproteinases 2 and 9 regulate activation of CD4+ and CD8+ T cells.Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopesNeutrophils sustain pathogenic CD8+ T cell responses in the heart.TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo.Distinct CD4+ helper T cells involved in primary and secondary responses to infection.Cross-priming for antitumor CTL induced by soluble Ag + polyI:C depends on the TICAM-1 pathway in mouse CD11c(+)/CD8α(+) dendritic cells.Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes.An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-SMechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytesAntivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen.Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition.Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes.Engineering protein for X-ray crystallography: the murine Major Histocompatibility Complex class II molecule I-Ad.Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptideDownregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12.T cell priming versus T cell tolerance induced by synthetic peptides.Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo.Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help.BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation.Ontogeny of T cell tolerance to peripherally expressed antigens.Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challengeSimian virus 40 T antigen as a carrier for the expression of cytotoxic T-lymphocyte recognition epitopes.Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence.Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein.
P2860
Q27642083-28E48746-9E70-467C-AA02-C38D1C4638DEQ27729958-FAF39040-AE65-40D6-B72A-889AA19D5E77Q30539566-462DFDB0-C204-4FF4-8A7F-AB34FBCE4A57Q30769959-C37A6E47-4DDE-4B12-86DF-81A765178594Q31993493-406152D9-CC57-4E53-A234-F18F7387F03EQ33723534-4EE99FEF-33F4-4FD2-AB34-DAD754855297Q33842444-77FE8E89-DFE8-40F9-8B08-4D7C275B7513Q33852549-661613D5-706D-4B9C-9993-31CDAA7B4C17Q33887085-43667B2C-0200-4AEC-9A16-3854F5725C2DQ33902103-390E4B51-E4DF-4B3A-B79F-A163DF73D3CCQ33902324-EB26A3B0-E47F-4A98-A263-BC0A47241BAAQ34195888-97C81A0A-E2B2-4ECC-9B2B-C0BADBB5FEFFQ34393155-377C6DBC-DB58-4D77-AC73-6C3843860858Q34681015-8479AE4E-60BC-4FB7-85A0-AD91BDD9BA1EQ34975904-1D0542E3-D1C9-4EE5-8F0E-49693925A1F8Q34985628-9CD38ABB-15FE-4D5E-9914-FCE3099D7F17Q35093159-5874363F-D048-4D29-AABE-EB5E98F5563CQ35843331-B5D6D85D-FABD-464F-9C6F-2E6337DF35DEQ35849294-891B843D-422B-4A5F-996E-F1A6E92083CDQ36066378-49ABCAD8-C712-41E2-B54E-E64E7AC9EBF7Q36194804-26BE6FC0-F33F-48B8-8695-153C38F7F162Q36230917-C36764E2-D358-4F97-8E9C-83715566371FQ36231070-10575BF0-C0D0-4C7D-98D0-4A1DFDE55079Q36231639-149FCB5A-FC24-4C6B-9EA4-D73B06879921Q36231954-F3FC510D-9AFF-4B7A-B71B-650D72965B57Q36232028-0EBD71D2-7336-4C95-A68A-08DF1644D3F6Q36232166-9F7D6DAB-F3F2-4D66-A981-9A59AA97B432Q36280801-0EF6BF8E-584C-4C12-B72C-ACA4DCC02C5BQ36350448-2E7E4652-CEA9-4F49-88C9-7A3F79545BEAQ36351136-CB485DA7-FEF9-40B3-AD04-2804B52EE9CDQ36363521-EA226665-ECD6-4253-9343-21F68CBE26AEQ36365135-126945E6-3E1D-4D89-B0F0-DA3217130213Q36375248-6C16CC7C-8F22-45BB-BE45-F61BE49CB8CCQ36380318-C5DDC953-0F01-49FC-8BD4-177C8D51241AQ36402877-FB2E1FB1-9243-4BC6-BDE6-C251C2465B54Q36453129-6765FF0A-439D-4A7B-AA5A-81379761C6D8Q36508925-AD3757E2-9EFE-43A2-953F-13925BBC473EQ36654693-55D05A6E-5133-4590-BC82-E3EBC9E824EDQ36683932-94206BDF-B450-43EF-A7E4-CDA30346C629Q36687045-9C43A224-4094-4DB6-9C4D-773D5735B30E
P2860
Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
@ast
Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
@en
type
label
Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
@ast
Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
@en
prefLabel
Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
@ast
Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
@en
P2860
P356
P1476
Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
@en
P2093
F R Carbone
P2860
P304
P356
10.1084/JEM.169.3.603
P407
P577
1989-03-01T00:00:00Z